For reference: FLOW · survodutide. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am being…
All questions
Newest first. 5.2k questions across 107 tags.
I have the report as a PDF with the chromatogram on page two, so I can quote specifics. I want a method I can write down and repeat, not a rule of thumb. I would…
For reference: 15 mg · survodutide. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping rules, not…
I have been reading across the programmes and the A1c numbers do not line up in any way I can make sense of. SURPASS-2 reports tirzepatide lowering A1c by more than 2…
What I am working with: a residual-solvent screen · a ten-person group buy. I would like to set this up properly once, rather than adjust it repeatedly. My budget is…
What I am working with: 37 °C · a GLP-1 receptor agonist. This is asserted often enough that I assumed it was established, and then I went looking for the source. I…
What I am working with: ERP · cagrilintide. This is asserted often enough that I assumed it was established, and then I went looking for the source. I have searched…
What I am working with: dulaglutide · 25 °C. This is a procedural question rather than a theoretical one, and I would like the procedure rather than the theory. What…
Stated plainly: FGP · Hangzhou · the Netherlands. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but not tight, and my…
What I have: mazdutide · purity figure. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
What I have: STEP 2 · nausea · 50 mg. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…
Numbers first: 25 units · 2.5 mg/mL. I would like to understand the steps well enough to explain them to someone else. I have access to a refrigerator with a logger…
Numbers first: FLOW · orforglipron. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…
What I have: mazdutide · room temperature. I would like to understand the steps well enough to explain them to someone else. I have access to a refrigerator with a…
What I have: cagrilintide · purity figure. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
The case in front of me: aspartimide formation · tirzepatide · 40 °C. This is one of those things that everyone repeats and nobody derives. This matters practically,…
The case in front of me: constipation · tirzepatide. This is one of those things that everyone repeats and nobody derives. This matters practically, not just…
Conditions: HbA1c · tirzepatide. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow the plan I write down, so I…
The specifics, since they change the answer: liraglutide · Chengdu. I am at the decision point and I would rather think it through than improvise. I would rather…
I have the report as a PDF with the chromatogram on page two, so I can quote specifics. Something has gone wrong and I would like to know how badly before I decide…
The particulars: SUSTAIN-6 · early satiety. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…
For reference: oral semaglutide · minus 20 °C · fourteen days. I am at the decision point and I would rather think it through than improvise. I would rather spend…
What I am working with: orforglipron · SURPASS-3. I have read the primary source rather than the summary, which has left me with more questions. I understand the…
Stated plainly: FGP · peptide mapping. The units are where I keep going wrong, so please be explicit about them. I have sanity-checked the order of magnitude and it…